Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis
- 1 March 2009
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 32 (2) , 94-103
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryJournal of Experimental Medicine, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Cytokines and joint erosion in arthritisNature Clinical Practice Rheumatology, 2007
- The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitisJournal of Neuroimmunology, 2007
- p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune EncephalomyelitisThe American Journal of Pathology, 2007
- Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesionBlood, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic NeuritisJournal of Experimental Medicine, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Normal embryo fibroblasts release transforming growth factors in a latent formJournal of Cellular Physiology, 1984